Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments
This review focuses upon interactions and potential therapeutic targets in the 'vicious
cycle'between hypoxia and neoangiogenesis following treatment of hepatocellular …
cycle'between hypoxia and neoangiogenesis following treatment of hepatocellular …
The role of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis
S Li, J Xu, H Zhang, J Hong, Y Si, T Yang, Y He… - Chemotherapy, 2021 - karger.com
Background: The main aim of this study was to investigate comprehensively the clinical
effect of hepatic arterial infusion chemotherapy (HAIC) on patients suffering from …
effect of hepatic arterial infusion chemotherapy (HAIC) on patients suffering from …
Predicting hyperprogressive disease in patients with advanced hepatocellular carcinoma treated with anti-programmed cell death 1 therapy
Background Hyperprogressive disease (HPD) is a new progressive pattern in patients with
advanced hepatocellular carcinoma (HCC) treated with programmed cell death 1 (PD-1) …
advanced hepatocellular carcinoma (HCC) treated with programmed cell death 1 (PD-1) …
Predictive factors for adverse event outcomes after transarterial radioembolization with yttrium-90 resin microspheres in Europe: results from the prospective …
G Maleux, T Albrecht, D Arnold, I Bargellini… - Cardiovascular and …, 2023 - Springer
Background Using data collected in the prospective observational study CIRSE Registry for
SIR-Spheres Therapy, the present study aimed at identifying predictors of adverse events …
SIR-Spheres Therapy, the present study aimed at identifying predictors of adverse events …
Ablative transarterial radioembolization improves survival in patients with HCC and portal vein tumor thrombus
L Cardarelli-Leite, J Chung, D Klass, V Marquez… - CardioVascular and …, 2020 - Springer
Purpose Patients with hepatocellular carcinoma and portal vein tumor thrombus have a poor
prognosis and limited therapeutic options. We sought to compare survival, tolerability, and …
prognosis and limited therapeutic options. We sought to compare survival, tolerability, and …
Present role and future perspectives of interventional radiology in the treatment of painful bone lesions
Interventional radiology has experienced an exponential growth in the last years. Nowadays
it is possible to treat painful benign lesions or metastases with optimal results in terms of …
it is possible to treat painful benign lesions or metastases with optimal results in terms of …
Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
X Han, Q Sun, M Xu, G Zhu, R Gao… - Seminars in Liver …, 2023 - thieme-connect.com
Immune checkpoint inhibitors (ICIs) have emerged as effective therapeutics for multiple
cancers. Nevertheless, as immunotherapeutic approaches are being extensively utilized …
cancers. Nevertheless, as immunotherapeutic approaches are being extensively utilized …
Precision imaging guidance in the era of precision oncology: An update of imaging tools for interventional procedures
C Floridi, M Cellina, G Irmici, A Bruno… - Journal of Clinical …, 2022 - mdpi.com
Interventional oncology (IO) procedures have become extremely popular in interventional
radiology (IR) and play an essential role in the diagnosis, treatment, and supportive care of …
radiology (IR) and play an essential role in the diagnosis, treatment, and supportive care of …
Radioembolization lung shunt estimation based on a 90Y pretreatment procedure: A phantom study
B Kunnen, S van der Velden, R Bastiaannet… - Medical …, 2018 - Wiley Online Library
Purpose Prior to 90Y radioembolization, a pretreatment procedure is performed, in which
99mTc‐macroaggerated albumin (99mTc‐MAA) is administered to estimate the amount of …
99mTc‐macroaggerated albumin (99mTc‐MAA) is administered to estimate the amount of …
The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study
MA Abdallah, N Wongjarupong… - Expert review of …, 2020 - Taylor & Francis
Objectives Yttrium-90 transarterial radioembolization (TARE) is a safe, effective modality of
locoregional therapy for intermediate and advanced-stage hepatocellular carcinoma (HCC) …
locoregional therapy for intermediate and advanced-stage hepatocellular carcinoma (HCC) …